BrainBlog

From MedPage Today : FDA Puts Early Alzheimer's Test on Hold By Peggy Peck, Executive Editor MedPage Today Published: March 18, 2011 [snip] "The FDA will not approve the novel contrast agent, florbetapir -- widely touted as a breakthrough for early diagnosis of Alzheimer's disease -- until manufacturer Eli Lilly puts a training program in place, the company announced." [snip] Read the article .

FierceBiotechResearch has an article which presents a very brief overview of the current Alzheimer's disease drug pipeline: It is available at the link below: Making sense of the Alzheimer's drug pipeline FierceBiotechResearch March 15, 2011 — 7:53am ET By Howard Lovy Read the full article If this area is new to you, the article will give you the names of some candidates that you can learn about as part of your introduction. There are many other overview articles and public resources available to you concerning clinical-trials research. You might wish, for example, to cross reference the names cited here with the ClinicalTrials.gov database. If you are a Brain Awareness Week visitor, you can visit the Alzheimer's Association or other national organizations in your country to learn more about Alzheimer's disease and dementia.

Untangling the brain by Nature Video 09 March 2011 Watch the YouTube video

From The New York Times : On the Left Hand, There Are No Easy Answers By PERRI KLASS, M.D. The New York Times Published: March 6, 2011 "The riddle of why about 10 percent of people are born with the left-dominant variety of this essentially human asymmetry remains." Read the article